2024 Q1 Form 10-K Financial Statement

#000181949324000050 Filed on March 29, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $13.16M $18.38M $44.52M
YoY Change 180.22% 114.4% 22.4%
Cost Of Revenue $10.37M $17.05M $45.81M
YoY Change 86.11% 3.04% -31.01%
Gross Profit $2.788M $1.327M -$1.290M
YoY Change -417.9% -116.64% -95.7%
Gross Profit Margin 21.18% 7.22% -2.9%
Selling, General & Admin $9.957M $9.012M $42.71M
YoY Change -25.71% -23.35% -15.66%
% of Gross Profit 357.14% 679.13%
Research & Development $3.074M $4.143M $19.59M
YoY Change -46.53% -33.03% -36.15%
% of Gross Profit 110.26% 312.21%
Depreciation & Amortization $900.0K $214.0K $3.314M
YoY Change -10.0% -75.46% 57.81%
% of Gross Profit 32.28% 16.13%
Operating Expenses $13.03M $13.16M $63.68M
YoY Change -31.96% -26.69% -21.7%
Operating Profit -$10.24M -$11.83M -$64.97M
YoY Change -48.86% -54.37% -41.66%
Interest Expense -$768.0K -$2.054M -$11.75M
YoY Change -74.37% -140.6% -182.82%
% of Operating Profit
Other Income/Expense, Net -$584.0K -$631.0K $1.690M
YoY Change -85.93% -153.57% -134.95%
Pretax Income -$11.00M -$13.81M -$75.82M
YoY Change -54.79% -29.82% 3.42%
Income Tax $5.000K $14.00K $21.00K
% Of Pretax Income
Net Earnings -$11.00M -$13.83M -$75.84M
YoY Change -54.78% -29.77% 3.43%
Net Earnings / Revenue -83.6% -75.24% -170.35%
Basic Earnings Per Share -$1.80 -$13.11
Diluted Earnings Per Share -$1.80 -$2.33 -$13.11
COMMON SHARES
Basic Shares Outstanding 7.750M shares 177.9M shares 5.787M shares
Diluted Shares Outstanding 6.108M shares 5.787M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $46.17M $11.64M $11.64M
YoY Change -27.88% -86.51% -86.51%
Cash & Equivalents $46.20M $11.64M $11.64M
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $9.292M $6.259M $6.259M
YoY Change 26.53% -43.84% -43.84%
Inventory $36.62M $37.84M $37.84M
Prepaid Expenses
Receivables $20.32M $15.95M $15.95M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $112.8M $71.70M $71.70M
YoY Change -17.34% -56.07% -56.07%
LONG-TERM ASSETS
Property, Plant & Equipment $18.23M $19.65M $19.65M
YoY Change -23.82% -21.82% -21.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.954M $2.338M $2.338M
YoY Change 117.13% 46.22% 46.22%
Total Long-Term Assets $22.18M $21.99M $21.99M
YoY Change -13.85% -17.75% -17.75%
TOTAL ASSETS
Total Short-Term Assets $112.8M $71.70M $71.70M
Total Long-Term Assets $22.18M $21.99M $21.99M
Total Assets $135.0M $93.68M $93.68M
YoY Change -16.79% -50.68% -50.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.272M $2.756M $2.756M
YoY Change -35.69% -4.83% -4.83%
Accrued Expenses $10.43M $9.099M $9.099M
YoY Change 44.19% 16.92% -2.29%
Deferred Revenue $332.0K $690.0K
YoY Change -56.54% -4.3%
Short-Term Debt $690.0K $0.00 $0.00
YoY Change -75.57% -100.0%
Long-Term Debt Due $2.046M $2.005M $2.005M
YoY Change -90.6% -92.53% -92.53%
Total Short-Term Liabilities $22.31M $19.57M $19.57M
YoY Change -45.38% -57.23% -57.23%
LONG-TERM LIABILITIES
Long-Term Debt $20.88M $21.39M $21.39M
YoY Change -10.94% -30.7% -30.7%
Other Long-Term Liabilities $24.33M $7.523M $7.523M
YoY Change 132.46% -31.61% 514.12%
Total Long-Term Liabilities $24.33M $28.92M $28.92M
YoY Change 132.46% 162.86% -9.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.31M $19.57M $19.57M
Total Long-Term Liabilities $24.33M $28.92M $28.92M
Total Liabilities $67.17M $48.49M $48.49M
YoY Change -7.3% -37.72% -37.72%
SHAREHOLDERS EQUITY
Retained Earnings -$164.3M -$153.3M
YoY Change 61.44% 97.97%
Common Stock $1.000K $1.000K
YoY Change -94.12% -94.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $67.81M $45.20M $45.20M
YoY Change
Total Liabilities & Shareholders Equity $135.0M $93.68M $93.68M
YoY Change -16.79% -50.68% -50.68%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$11.00M -$13.83M -$75.84M
YoY Change -54.78% -29.77% 3.43%
Depreciation, Depletion And Amortization $900.0K $214.0K $3.314M
YoY Change -10.0% -75.46% 57.81%
Cash From Operating Activities -$14.60M -$626.0K -$39.29M
YoY Change -4.74% -97.2% -69.3%
INVESTING ACTIVITIES
Capital Expenditures $30.00K $225.0K $1.385M
YoY Change -88.14% -89.84% -90.19%
Acquisitions
YoY Change
Other Investing Activities $51.36M -$5.000K $52.02M
YoY Change 122.65% -100.05% -46.28%
Cash From Investing Activities $51.33M -$220.0K $50.63M
YoY Change 124.99% -103.06% -38.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.209M
YoY Change -71.95%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$1.093M -10.87M -38.38M
YoY Change -88.7% -348.55% -159.27%
NET CHANGE
Cash From Operating Activities -$14.60M -626.0K -39.29M
Cash From Investing Activities $51.33M -220.0K 50.63M
Cash From Financing Activities -$1.093M -10.87M -38.38M
Net Change In Cash $35.64M -11.71M -27.04M
YoY Change -1730.51% 8.52% -238.65%
FREE CASH FLOW
Cash From Operating Activities -$14.60M -$626.0K -$39.29M
Capital Expenditures $30.00K $225.0K $1.385M
Free Cash Flow -$14.63M -$851.0K -$40.67M
YoY Change -6.09% -96.54% -71.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-39598
CY2023 dei Entity Registrant Name
EntityRegistrantName
XOS, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1550505
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
3550 Tyburn Street
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90065
CY2023 dei City Area Code
CityAreaCode
818
CY2023 dei Local Phone Number
LocalPhoneNumber
316-1890
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Auditor Firm
AuditorFirmId
248
CY2023 dei Auditor Name
AuditorName
GRANT THORNTON LLP
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
3044000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8238000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
50648000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8100000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
163201000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
18581000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6555000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19589000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30679000 usd
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6388000 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9547000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7863000 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7906000 usd
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001819493
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0333
CY2023Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0333
CY2023Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0333
CY2023 us-gaap Sales Type Lease Income Comprehensive Income Extensible List
SalesTypeLeaseIncomeComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2023#Revenues
CY2023 us-gaap Operating Lease Income Comprehensive Income Extensible List
OperatingLeaseIncomeComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2023#Revenues
CY2023Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2022Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2022Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2022Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0333
CY2023Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0333
CY2023 us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#GainLossOnDerivativeInstrumentsNetPretax
CY2022 us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#GainLossOnDerivativeInstrumentsNetPretax
CY2023Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0333
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7750258 shares
CY2023Q2 dei Entity Public Float
EntityPublicFloat
14476000 usd
CY2023 dei Auditor Location
AuditorLocation
Los Angeles, California
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11640000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35631000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15142000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
37843000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
57540000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7070000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
71695000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
14660000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4991000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2338000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1599000 usd
CY2023Q4 us-gaap Assets
Assets
93684000 usd
CY2022Q4 us-gaap Assets
Assets
189936000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2756000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2896000 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
26849000 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
405000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
16817000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15616000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19573000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
45766000 usd
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
19920000 usd
CY2022Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
19870000 usd
CY2023Q4 xos Derivative Instrument Contingent Consideration Liability
DerivativeInstrumentContingentConsiderationLiability
39000 usd
CY2022Q4 xos Derivative Instrument Contingent Consideration Liability
DerivativeInstrumentContingentConsiderationLiability
564000 usd
CY2023Q4 xos Warrants And Rights Outstanding Noncurrent
WarrantsAndRightsOutstandingNoncurrent
395000 usd
CY2022Q4 xos Warrants And Rights Outstanding Noncurrent
WarrantsAndRightsOutstandingNoncurrent
661000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8561000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11000000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
48488000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
77861000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5941000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5941000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5627000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5627000 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
198456000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
190231000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-153261000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-77418000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-739000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
45196000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
112075000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
93684000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
189936000 usd
CY2023 us-gaap Revenues
Revenues
44523000 usd
CY2022 us-gaap Revenues
Revenues
36376000 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
45813000 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
66405000 usd
CY2023 us-gaap Gross Profit
GrossProfit
-1290000 usd
CY2022 us-gaap Gross Profit
GrossProfit
-30029000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
37698000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41093000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
63675000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
81319000 usd
CY2023 xos Derivative Instrument Change In Amount Of Contingent Consideration Liability
DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability
-519000 usd
CY2022 xos Derivative Instrument Change In Amount Of Contingent Consideration Liability
DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability
-28682000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-75822000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-73317000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-75843000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-73325000 usd
CY2023 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
0 usd
CY2022 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
0 usd
CY2023 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
739000 usd
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-358000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-75104000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-73683000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-13.11
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-13.31
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-13.11
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-13.32
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5787000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5508000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5787000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5812000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
174393000 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6000 usd
CY2022 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
449000 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2123000 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4372000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-73683000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
112075000 usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8000 usd
CY2023 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000 usd
CY2023 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1060000 usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
212000 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1201000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-75104000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
45196000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-75843000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-73325000 usd
CY2023 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
3314000 usd
CY2022 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
2065000 usd
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1564000 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1566000 usd
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6201000 usd
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2577000 usd
CY2023 xos Amortization Of Insurance Premiums
AmortizationOfInsurancePremiums
4353000 usd
CY2022 xos Amortization Of Insurance Premiums
AmortizationOfInsurancePremiums
1338000 usd
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
-1876000 usd
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
5661000 usd
CY2023 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
1591000 usd
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2023 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
671000 usd
CY2022 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
14184000 usd
CY2023 xos Derivative Instrument Change In Amount Of Contingent Consideration Liability
DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability
-519000 usd
CY2022 xos Derivative Instrument Change In Amount Of Contingent Consideration Liability
DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability
-28682000 usd
CY2023 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
-91000 usd
CY2022 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
-147000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
7906000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
5222000 usd
CY2023 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-134000 usd
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1368000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6982000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4942000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-22049000 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
31285000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4244000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-6413000 usd
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
739000 usd
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1093000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-133000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7268000 usd
CY2023 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
4518000 usd
CY2022 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
6462000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39286000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-127960000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1385000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14113000 usd
CY2023 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
1295000 usd
CY2022 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
0 usd
CY2023 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
50720000 usd
CY2022 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
96823000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
50630000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
82710000 usd
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
54300000 usd
CY2023 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
403000 usd
CY2023 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
3770000 usd
CY2022 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
3627000 usd
CY2023 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
4832000 usd
CY2022 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
1562000 usd
CY2023 xos Proceeds From Equipment Financing Financing Activities
ProceedsFromEquipmentFinancingFinancingActivities
0 usd
CY2022 xos Proceeds From Equipment Financing Financing Activities
ProceedsFromEquipmentFinancingFinancingActivities
6312000 usd
CY2023 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
3026000 usd
CY2022 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
1392000 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8000 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6000 usd
CY2023 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
1640000 usd
CY2022 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 usd
CY2023 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
32800000 usd
CY2022 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 usd
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1060000 usd
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
449000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1201000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4310000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-38379000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
64749000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-27035000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
19499000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38675000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19176000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11640000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38675000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11640000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35631000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
3044000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11640000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38675000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
1524000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 xos Increase Decrease In Capital Expenditures Accrual
IncreaseDecreaseInCapitalExpendituresAccrual
7000 usd
CY2022 xos Increase Decrease In Capital Expenditures Accrual
IncreaseDecreaseInCapitalExpendituresAccrual
42000 usd
CY2023 xos Recognition Of Lease Liabilities Upon Adoption Of Accounting Standard
RecognitionOfLeaseLiabilitiesUponAdoptionOfAccountingStandard
0 usd
CY2022 xos Recognition Of Lease Liabilities Upon Adoption Of Accounting Standard
RecognitionOfLeaseLiabilitiesUponAdoptionOfAccountingStandard
7682000 usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
437000 usd
CY2023 xos Conversion Of Interest Payable On Convertible Debentures
ConversionOfInterestPayableOnConvertibleDebentures
12000 usd
CY2022 xos Conversion Of Interest Payable On Convertible Debentures
ConversionOfInterestPayableOnConvertibleDebentures
122000 usd
CY2023 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
200000 usd
CY2022 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2000000 usd
CY2023Q4 us-gaap Investments And Cash
InvestmentsAndCash
11600000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39300000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-128000000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well as reported amounts of revenues and expenses during the reporting periods. The areas with significant estimates and judgments include, among others, inventory valuation, incremental borrowing rates for assessing operating and financing lease liabilities, useful lives of property and equipment, stock-based compensation, product warranty liability, and valuation of convertible debt and related embedded derivatives, common stock warrant liability and earn-out shares liability. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates, and such differences could be material to the Company’s financial statements.</span></div>
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
62000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
39000 usd
CY2023 xos Property Plant And Equipment Capitalization Threshold
PropertyPlantAndEquipmentCapitalizationThreshold
5000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1099000 usd
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
177000 usd
CY2023 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1304000 usd
CY2022 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
220000 usd
CY2023 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1511000 usd
CY2022 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1142000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1306000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1099000 usd
CY2023 xos Derivative Instrument Contingent Consideration Liability Earnout Period
DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriod
P5Y
CY2023 xos Derivative Instrument Contingent Consideration Liability Earnout Period
DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriod
P5Y
CY2023 us-gaap Advertising Expense
AdvertisingExpense
300000 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
1300000 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Concentrations of Credit and Business Risk</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. As o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">f December 31, 2023 and 2022, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such accounts.</span></div>
CY2023 xos Defined Contribution Plan Auto Enrollment Contributions Per Employee Percent
DefinedContributionPlanAutoEnrollmentContributionsPerEmployeePercent
0.03
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
0 usd
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
0 usd
CY2023Q4 us-gaap Marketable Securities
MarketableSecurities
0 usd
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
50600000 usd
CY2023 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
1137000 usd
CY2022 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
1715000 usd
CY2023 us-gaap Revenues
Revenues
44523000 usd
CY2022 us-gaap Revenues
Revenues
36376000 usd
CY2023 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
37000 usd
CY2023Q4 us-gaap Lessor Sales Type Lease Term Of Contract1
LessorSalesTypeLeaseTermOfContract1
P60M
CY2023 us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
1500000 usd
CY2023 us-gaap Cost Of Goods Sold Sales Type Lease
CostOfGoodsSoldSalesTypeLease
1300000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
37800000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
57500000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
30357000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
40271000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3033000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
4618000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4453000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12651000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
37843000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
57540000 usd
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
-1900000 usd
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
5700000 usd
CY2023Q4 xos Prepaid Inventory
PrepaidInventory
1745000 usd
CY2022Q4 xos Prepaid Inventory
PrepaidInventory
2372000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2796000 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1299000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
811000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
290000 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1310000 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2289000 usd
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
408000 usd
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1850000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7070000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8100000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7435000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7589000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
690000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
193000 usd
CY2023Q4 xos Deposits Of Customers Current
DepositsOfCustomersCurrent
2364000 usd
CY2022Q4 xos Deposits Of Customers Current
DepositsOfCustomersCurrent
721000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
1306000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
1099000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
350000 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
303000 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1003000 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
2065000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1664000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1530000 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2005000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2116000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
16817000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15616000 usd
CY2023 xos Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
400000 usd
CY2022 xos Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
800000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
2985000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
784000 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
593000 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
942000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3511000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5174000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1472000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
4100000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8561000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11000000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4991000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6555000 usd
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
5931000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
7979000 usd
CY2023Q4 xos Operating Lease Right Of Use Asset And Finance Lease Right Of Use Asset After Accumulated Amortization
OperatingLeaseRightOfUseAssetAndFinanceLeaseRightOfUseAssetAfterAccumulatedAmortization
10922000 usd
CY2022Q4 xos Operating Lease Right Of Use Asset And Finance Lease Right Of Use Asset After Accumulated Amortization
OperatingLeaseRightOfUseAssetAndFinanceLeaseRightOfUseAssetAfterAccumulatedAmortization
14534000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1664000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1530000 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2005000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2116000 usd
CY2023Q4 xos Operating Lease Liability Current And Finance Lease Liability Current
OperatingLeaseLiabilityCurrentAndFinanceLeaseLiabilityCurrent
3669000 usd
CY2022Q4 xos Operating Lease Liability Current And Finance Lease Liability Current
OperatingLeaseLiabilityCurrentAndFinanceLeaseLiabilityCurrent
3646000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3511000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5174000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1472000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
4100000 usd
CY2023Q4 xos Operating Lease Liability Noncurrent And Finance Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrentAndFinanceLeaseLiabilityNoncurrent
4983000 usd
CY2022Q4 xos Operating Lease Liability Noncurrent And Finance Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrentAndFinanceLeaseLiabilityNoncurrent
9274000 usd
CY2023Q4 xos Operating Lease Liability And Finance Lease Liability
OperatingLeaseLiabilityAndFinanceLeaseLiability
8652000 usd
CY2022Q4 xos Operating Lease Liability And Finance Lease Liability
OperatingLeaseLiabilityAndFinanceLeaseLiability
12920000 usd
CY2023Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2023 us-gaap Lease Cost
LeaseCost
2200000 usd
CY2022 us-gaap Lease Cost
LeaseCost
2500000 usd
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
24000 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
300000 usd
CY2023 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1378000 usd
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
848000 usd
CY2023 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
418000 usd
CY2022 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
428000 usd
CY2023 xos Finance Lease Expense
FinanceLeaseExpense
1796000 usd
CY2022 xos Finance Lease Expense
FinanceLeaseExpense
1276000 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
1860000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
1734000 usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
437000 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y10M24D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y10M24D
CY2023Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M24D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2023Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.065
CY2022Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.069
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1907000 usd
CY2023Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
2219000 usd
CY2023Q4 xos Lessee Operating Lease Liability And Finance Lease Liability To Be Paid Year One
LesseeOperatingLeaseLiabilityAndFinanceLeaseLiabilityToBePaidYearOne
4126000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1962000 usd
CY2023Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1119000 usd
CY2023Q4 xos Lessee Operating Lease Liability And Finance Lease Liability To Be Paid Year Two
LesseeOperatingLeaseLiabilityAndFinanceLeaseLiabilityToBePaidYearTwo
3081000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1631000 usd
CY2023Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
317000 usd
CY2023Q4 xos Lessee Operating Lease Liability And Finance Lease Liability To Be Paid Year Three
LesseeOperatingLeaseLiabilityAndFinanceLeaseLiabilityToBePaidYearThree
1948000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
116000 usd
CY2023Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
128000 usd
CY2023Q4 xos Lessee Operating Lease Liability And Finance Lease Liability To Be Paid Year Four
LesseeOperatingLeaseLiabilityAndFinanceLeaseLiabilityToBePaidYearFour
244000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5616000 usd
CY2023Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
3783000 usd
CY2023Q4 xos Lessee Operating Lease Liability And Finance Lease Liability Payment Due
LesseeOperatingLeaseLiabilityAndFinanceLeaseLiabilityPaymentDue
9399000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
441000 usd
CY2023Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
306000 usd
CY2023Q4 xos Lessee Operating Lease Liability And Finance Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityAndFinanceLeaseLiabilityUndiscountedExcessAmount
747000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5175000 usd
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
3477000 usd
CY2023Q4 xos Lessee Operating Lease Liability And Finance Lease Liability
LesseeOperatingLeaseLiabilityAndFinanceLeaseLiability
8652000 usd
CY2021Q3 xos Derivative Instrument Contingent Consideration Liability Shares
DerivativeInstrumentContingentConsiderationLiabilityShares
540000 shares
CY2023Q4 xos Derivative Instrument Contingent Consideration Liability
DerivativeInstrumentContingentConsiderationLiability
39000 usd
CY2022Q4 xos Derivative Instrument Contingent Consideration Liability
DerivativeInstrumentContingentConsiderationLiability
600000 usd
CY2023 xos Derivative Instrument Gain Loss Change In Amount Of Contingent Consideration Liability
DerivativeInstrumentGainLossChangeInAmountOfContingentConsiderationLiability
500000 usd
CY2022 xos Derivative Instrument Gain Loss Change In Amount Of Contingent Consideration Liability
DerivativeInstrumentGainLossChangeInAmountOfContingentConsiderationLiability
28700000 usd
CY2022Q3 us-gaap Debt Instrument Convertible Threshold Consecutive Trading Days1
DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
3 day
CY2022Q3 xos Debt Instrument Convertible Redemption Notice Period
DebtInstrumentConvertibleRedemptionNoticePeriod
P10D
CY2022Q3 xos Debt Instrument Convertible Monthly Payments Period From Triggering Date
DebtInstrumentConvertibleMonthlyPaymentsPeriodFromTriggeringDate
P10D
CY2023 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
32800000 usd
CY2023Q4 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
3200000 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
51387000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
739000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
50648000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1789000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
2000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
48859000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
737000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
50648000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
739000 usd
CY2023 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0 usd
CY2022 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0 usd
CY2023 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
91000 usd
CY2022 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
147000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
51387000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
50648000 usd
CY2022 xos Debt Securities Available For Sale Maturity Allocation Contractual Maturity
DebtSecuritiesAvailableForSaleMaturityAllocationContractualMaturity
P0Y3M18D
CY2023Q4 xos Capital Stock Shares Authorized
CapitalStockSharesAuthorized
1010000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 xos Common Stock Voting Rights Number Of Votes
CommonStockVotingRightsNumberOfVotes
1 vote
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q2 xos Debt Instrument Redemption Prepayment Reduction Period Prior To Prepayment Date
DebtInstrumentRedemptionPrepaymentReductionPeriodPriorToPrepaymentDate
P30D
CY2023 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
138795 shares
CY2022 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
60317 shares
CY2023 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
1200000 usd
CY2022 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
4300000 usd
CY2023Q4 xos Sale Of Stock Remaining Commitment Amount Available
SaleOfStockRemainingCommitmentAmountAvailable
119500000 usd
CY2023 xos Class Of Warrant Or Right Fair Market Value Threshold Consecutive Trading Days Ending On Third Trading Day Prior To Notice Of Redemption
ClassOfWarrantOrRightFairMarketValueThresholdConsecutiveTradingDaysEndingOnThirdTradingDayPriorToNoticeOfRedemption
P10D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
22512 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
52408 shares
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.59
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.50
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M20D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
670047 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
17037 shares
CY2023 xos Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
0.72
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.47
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
189480 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
12859 shares
CY2023 xos Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue
0.73
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.54
CY2023 xos Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodIntrinsicValue
137500 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
22512 shares
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.40
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.51
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y6M18D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
168194 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
22180 shares
CY2023 xos Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageGrantDateFairValue
0.39
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.51
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y5M15D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
165723 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
200000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
700000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7900000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5200000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5222000 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
9200000 usd
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y4M13D
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
22662000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
23052000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
8002000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
4471000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
14660000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
18581000 usd
CY2023 us-gaap Depreciation
Depreciation
3300000 usd
CY2022 us-gaap Depreciation
Depreciation
2100000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-75822000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-73317000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
0 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
0 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-75822000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-73317000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
21000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
8000 usd
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
21000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
8000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.0162
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.0093
CY2023 xos Effective Income Tax Rate Reconciliation Adjustments On Earnout Interests Liability Percent
EffectiveIncomeTaxRateReconciliationAdjustmentsOnEarnoutInterestsLiabilityPercent
0.0014
CY2022 xos Effective Income Tax Rate Reconciliation Adjustments On Earnout Interests Liability Percent
EffectiveIncomeTaxRateReconciliationAdjustmentsOnEarnoutInterestsLiabilityPercent
0.0822
CY2023 xos Effective Income Tax Rate Reconciliation Adjustments On Derivative Liability Percent
EffectiveIncomeTaxRateReconciliationAdjustmentsOnDerivativeLiabilityPercent
0.0007
CY2022 xos Effective Income Tax Rate Reconciliation Adjustments On Derivative Liability Percent
EffectiveIncomeTaxRateReconciliationAdjustmentsOnDerivativeLiabilityPercent
0.0196
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.0113
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.0310
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0695
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.1041
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2759
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.4479
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0011
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0102
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0003
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0001
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
55792000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
39061000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards General Business
DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness
6765000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards General Business
DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness
5622000 usd
CY2023Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
8363000 usd
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
5937000 usd
CY2023Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
2055000 usd
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
2236000 usd
CY2023Q4 xos Deferred Tax Assets Fair Value Adjustments
DeferredTaxAssetsFairValueAdjustments
0 usd
CY2022Q4 xos Deferred Tax Assets Fair Value Adjustments
DeferredTaxAssetsFairValueAdjustments
199000 usd
CY2023Q4 xos Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
1386000 usd
CY2022Q4 xos Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
1811000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
607000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1092000 usd
CY2023Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
56000 usd
CY2022Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1298000 usd
CY2022Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1815000 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1106000 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
932000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
77428000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
58705000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
75306000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
54572000 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2122000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4133000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
567000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
998000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
1338000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
1770000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
217000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
1365000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2122000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
4133000 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
75300000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
54600000 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
429600000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-75843000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-73325000 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-75843000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-73325000 usd
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 usd
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
7350000 usd
CY2023 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 usd
CY2022 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
3267000 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-75843000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-77408000 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5787000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5508000 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-13.11
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-13.31
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5787000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5508000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5787000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5812000 shares
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-13.11
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-13.32
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001819493-24-000050-index-headers.html Edgar Link pending
0001819493-24-000050-index.html Edgar Link pending
0001819493-24-000050.txt Edgar Link pending
0001819493-24-000050-xbrl.zip Edgar Link pending
a202310-kexhibit1014.htm Edgar Link pending
a202310-kexhibit211.htm Edgar Link pending
a202310-kexhibit231.htm Edgar Link pending
a202310-kexhibit311.htm Edgar Link pending
a202310-kexhibit312.htm Edgar Link pending
a202310-kexhibit321.htm Edgar Link pending
a202310-kexhibit971.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xos-20231231.htm Edgar Link pending
xos-20231231.xsd Edgar Link pending
xos-20231231_g1.jpg Edgar Link pending
xos-20231231_def.xml Edgar Link unprocessable
xos-20231231_g2.jpg Edgar Link pending
xos-20231231_g3.jpg Edgar Link pending
xos-20231231_g4.jpg Edgar Link pending
xos-20231231_pre.xml Edgar Link unprocessable
xos-20231231_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
xos-20231231_lab.xml Edgar Link unprocessable
xos-20231231_cal.xml Edgar Link unprocessable